These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 2522789

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neuromuscular block with doxacurium (BW A938U) in patients with normal or absent renal function.
    Cashman JN, Luke JJ, Jones RM.
    Br J Anaesth; 1990 Feb; 64(2):186-92. PubMed ID: 2138489
    [Abstract] [Full Text] [Related]

  • 4. Clinical pharmacology of doxacurium chloride. A new long-acting nondepolarizing muscle relaxant.
    Basta SJ, Savarese JJ, Ali HH, Embree PB, Schwartz AF, Rudd GD, Wastila WB.
    Anesthesiology; 1988 Oct; 69(4):478-86. PubMed ID: 2972233
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Doxacurium pharmacodynamics in children during volatile and opioid-based anaesthesia.
    Kern C, Tassonyi E, Rouge JC, Wilder-Smith OH, Pittet JF.
    Anaesthesia; 1996 Apr; 51(4):361-4. PubMed ID: 8686826
    [Abstract] [Full Text] [Related]

  • 7. Pharmacodynamic and hemodynamic effects of mivacurium in infants anesthetized with halothane and nitrous oxide.
    Goudsouzian NG, Denman W, Schwartz A, Shorten G, Foster V, Samara B.
    Anesthesiology; 1993 Nov; 79(5):919-25. PubMed ID: 8239009
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical pharmacology of mivacurium chloride (BW B1090U) in children during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia.
    Sarner JB, Brandom BW, Woelfel SK, Dong ML, Horn MC, Cook DR, McNulty BF, Foster VJ.
    Anesth Analg; 1989 Feb; 68(2):116-21. PubMed ID: 2521547
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuromuscular and cardiovascular effects of mivacurium chloride (BW B109OU) during nitrous oxide-narcotic, nitrous oxide-halothane and nitrous oxide-isoflurane anesthesia in surgical patients.
    Pearson KS, From RP, Choi WW, Abou-Donia M, Sokoll MD.
    Middle East J Anaesthesiol; 1990 Jun; 10(5):469-78. PubMed ID: 2146482
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children.
    Bevan JC, Purday JP, Reimer EJ, Bevan DR.
    Can J Anaesth; 1994 Nov; 41(11):1074-80. PubMed ID: 7828255
    [Abstract] [Full Text] [Related]

  • 15. The neuromuscular blocking and cardiovascular effects of doxacurium chloride in patients receiving nitrous oxide narcotic anesthesia.
    Murray DJ, Mehta MP, Choi WW, Forbes RB, Sokoll MD, Gergis SD, Rudd GD, Abou-Donia MM.
    Anesthesiology; 1988 Oct; 69(4):472-7. PubMed ID: 3177909
    [Abstract] [Full Text] [Related]

  • 16. The clinical pharmacology of doxacurium in young adults and in elderly patients.
    Martlew RA, Harper NJ.
    Anaesthesia; 1995 Sep; 50(9):779-82. PubMed ID: 7573867
    [Abstract] [Full Text] [Related]

  • 17. Neuromuscular and cardiovascular effects of mivacurium chloride (BW B1090U) during nitrous oxide-fentanyl-thiopentone and nitrous oxide-halothane anaesthesia.
    From RP, Pearson KS, Choi WW, Abou-Donia M, Sokoll MD.
    Br J Anaesth; 1990 Feb; 64(2):193-8. PubMed ID: 2138490
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neuromuscular effects of atracurium during halothane-nitrous oxide and enflurane-nitrous oxide anesthesia in humans.
    Rupp SM, McChristian JW, Miller RD.
    Anesthesiology; 1985 Jul; 63(1):16-9. PubMed ID: 3160265
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.